key: cord-0758133-6z17135u
authors: Cade, Brian E.; Dashti, Hassan S.; Hassan, Syed M.; Redline, Susan; Karlson, Elizabeth W.
title: Sleep Apnea and COVID-19 Mortality and Hospitalization
date: 2020-11-15
journal: Am J Respir Crit Care Med
DOI: 10.1164/rccm.202006-2252le
sha: cd01a8808f63be5e2b96c6d1d64dd28f39adf294
doc_id: 758133
cord_uid: 6z17135u

nan

The sample was adult nonemployee participants with positive COVID-19 RNA PCR diagnostic results who had available demographic data, a minimum of two clinical notes, two encounters, and three International Classification of Disease (ICD) diagnoses of any disease (to minimize the effect of minimal EHR documentation in participants with out-of-network care). Participants were further restricted to include those with either zero or two or more ICD-9 or ICD-10 diagnoses of sleep apnea or obstructive sleep apnea on different dates (to minimize the effect of rule-out diagnosis codes). Natural language processing (10) was used to obtain documentation of continuous positive airway pressure (CPAP) usage in the year before the first COVID-19 test.

The sample of 4,668 patients included 55.6% females with a median age of 56.1 years (interquartile range, 40.5-71.1) and body mass index (BMI) of 28. 8 

The results of this U.S. healthcare system-based analysis of mortality and markers of severe morbidity identify sleep apnea as a risk factor for COVID-19 mortality, highlighting the need for close monitoring of patients with sleep apnea who become infected. Study strengths include analysis of a comprehensive electronic health data set and inclusion of a "data floor" to exclude participants with insufficient clinical data. Outcomes were based on a relatively long period of observation (median 31 d of follow-up) within a large healthcare system serving a diverse population and an area with high COVID-19 prevalence. Overall prevalence of sleep apnea, however, was lower than in community-based epidemiological studies, likely leading to some misclassification and attenuation of effect sizes. The CPAP analysis results are consistent with associations being driven by the untreated group; however, we caution that the analysis is limited by a lack of adherence data and should be replicated in a larger study. Although associations were somewhat reduced after adjusting for BMI, a common comorbidity of sleep apnea, the magnitude of effect and underlying biological plausibility of pathways linking sleep apnea to COVID-19-related morbidity highlight the importance of improved efforts to recognize sleep apnea in individuals presenting with COVID-19 infection. Given the urgent need to target mechanistic pathways underlying COVID-19 morbidity, research is warranted to understand whether sleep apnea-related hypoxemia, endothelial dysfunction, coagulopathy, inflammation, cardiac dysfunction, and other related pathologies contribute to the excessive COVID-19 morbidity and mortality observed in obese, minority, and other individuals at risk for sleep apnea. n

the Northwell COVID-19 Research Consortium. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area

Severe outcomes among patients with coronavirus disease 2019 (COVID-19) -United States

The last 25 years of obstructive sleep apnea epidemiology-and the next 25?

Sleep apnoea and endothelial dysfunction: an individual patient data meta-analysis

Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea

Oxidative stress in obstructive sleep apnea and intermittent hypoxia--revisited--the bad ugly and good: implications to the heart and brain

Association between obstructive sleep apnea and communityacquired pneumonia

Obstructive sleep apnea and subclinical interstitial lung disease in the Multi-Ethnic Study of Atherosclerosis (MESA)

Infrastructure for personalized medicine at partners healthCare

Mayo clinical Text Analysis and Knowledge Extraction System (cTAKES): architecture, component evaluation and applications